Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
3
Ongoing
380
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
3
Trials by status
Not yet recruiting
2
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World PracticeAlzheimer's diseaseN/ANot yet recruiting140
Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Researchmild-to-moderate ADN/ANot yet recruiting120
Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With LecanemabAmyloid biomarker required (PET/CSF)N/ARecruiting120